(+)-alpha-viniferin multiple interactions EXP 6480464 alpha-viniferin inhibits the reaction [IFNG protein results in increased expression of CXCL9 mRNA] and alpha-viniferin inhibits the reaction [IFNG protein results in increased expression of CXCL9 protein] CTD PMID:20424383 (-)-demecolcine increases expression ISO CXCL9 (Homo sapiens) 6480464 Demecolcine results in increased expression of CXCL9 mRNA CTD PMID:23649840 (1->4)-beta-D-glucan multiple interactions EXP 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of CXCL9 mRNA CTD PMID:36331819 1,2-dichloroethane decreases expression EXP 6480464 ethylene dichloride results in decreased expression of CXCL9 mRNA CTD PMID:28189721 and PMID:28960355 1,2-dimethylhydrazine multiple interactions ISO Cxcl9 (Rattus norvegicus) 6480464 [APC protein affects the susceptibility to 1 and 2-Dimethylhydrazine] which results in increased expression of CXCL9 mRNA CTD PMID:27840820 1,2-dimethylhydrazine decreases expression EXP 6480464 1 and 2-Dimethylhydrazine results in decreased expression of CXCL9 mRNA CTD PMID:22206623 1,3-dinitrobenzene increases expression ISO Cxcl9 (Rattus norvegicus) 6480464 3-dinitrobenzene results in increased expression of CXCL9 mRNA CTD PMID:21983209 1-chloro-2,4-dinitrobenzene increases expression EXP 6480464 Dinitrochlorobenzene results in increased expression of CXCL9 mRNA CTD PMID:21404309 17alpha-ethynylestradiol multiple interactions EXP 6480464 CXCL10 promotes the reaction [Ethinyl Estradiol results in increased expression of CXCL9 mRNA] more ... CTD PMID:12072388 and PMID:36329302 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of CXCL9 mRNA CTD PMID:36329302 17beta-estradiol multiple interactions ISO CXCL9 (Homo sapiens) 6480464 [Progesterone co-treated with Estradiol] results in increased expression of CXCL9 mRNA CTD PMID:18692832 17beta-estradiol multiple interactions ISO Cxcl9 (Rattus norvegicus) 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CXCL9 mRNA CTD PMID:32741896 17beta-estradiol 3-benzoate multiple interactions ISO Cxcl9 (Rattus norvegicus) 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CXCL9 mRNA CTD PMID:32741896 2,2',4,4',5,5'-hexachlorobiphenyl increases expression ISO CXCL9 (Homo sapiens) 6480464 2 more ... CTD PMID:23146750 2,2',4,4'-Tetrabromodiphenyl ether affects expression EXP 6480464 2 more ... CTD PMID:30294300 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of CXCL9 mRNA CTD PMID:21041162 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Cxcl9 (Rattus norvegicus) 6480464 Tetrachlorodibenzodioxin affects the expression of CXCL9 mRNA CTD PMID:32109520 and PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Cxcl9 (Rattus norvegicus) 6480464 Tetrachlorodibenzodioxin results in increased expression of CXCL9 mRNA CTD PMID:15644576 and PMID:21215274 2,3,7,8-Tetrachlorodibenzofuran decreases expression ISO Cxcl9 (Rattus norvegicus) 6480464 2 more ... CTD PMID:32109520 2,4,6-trinitrobenzenesulfonic acid increases expression EXP 6480464 Trinitrobenzenesulfonic Acid results in increased expression of CXCL9 mRNA CTD PMID:17982090 2,4,6-trinitrotoluene affects expression ISO Cxcl9 (Rattus norvegicus) 6480464 Trinitrotoluene affects the expression of CXCL9 mRNA CTD PMID:21346803 3,4-methylenedioxymethamphetamine decreases expression EXP 6480464 N-Methyl-3 and 4-methylenedioxyamphetamine results in decreased expression of CXCL9 mRNA CTD PMID:26251327 3-chloropropane-1,2-diol decreases expression ISO Cxcl9 (Rattus norvegicus) 6480464 alpha-Chlorohydrin results in decreased expression of CXCL9 mRNA CTD PMID:28522335 3-isobutyl-1-methyl-7H-xanthine multiple interactions EXP 6480464 [Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of CXCL9 mRNA and TNF protein promotes the reaction [[Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of CXCL9 mRNA] CTD PMID:23503329 4,4'-diaminodiphenylmethane increases expression ISO Cxcl9 (Rattus norvegicus) 6480464 4 and 4'-diaminodiphenylmethane results in increased expression of CXCL9 mRNA CTD PMID:25380136 4,4'-diaminodiphenylmethane increases expression EXP 6480464 4 and 4'-diaminodiphenylmethane results in increased expression of CXCL9 mRNA CTD PMID:18648102 4-(ethoxymethylene)-2-phenyloxazol-5-one decreases expression EXP 6480464 Oxazolone results in decreased expression of CXCL9 mRNA CTD PMID:11379042 4-(ethoxymethylene)-2-phenyloxazol-5-one increases expression EXP 6480464 Oxazolone results in increased expression of CXCL9 mRNA CTD PMID:19647056 more ... 4-(ethoxymethylene)-2-phenyloxazol-5-one increases expression ISO Cxcl9 (Rattus norvegicus) 6480464 Oxazolone results in increased expression of CXCL9 mRNA CTD PMID:21893156 4-hydroperoxycyclophosphamide decreases expression EXP 6480464 perfosfamide results in decreased expression of CXCL9 mRNA CTD PMID:19429390 4-hydroxyphenyl retinamide decreases expression EXP 6480464 Fenretinide results in decreased expression of CXCL9 mRNA CTD PMID:28973697 4-nitroquinoline N-oxide increases expression EXP 6480464 4-Nitroquinoline-1-oxide results in increased expression of CXCL9 mRNA CTD PMID:22561872 5-aza-2'-deoxycytidine affects methylation ISO CXCL9 (Homo sapiens) 6480464 Decitabine affects the methylation of CXCL9 promoter CTD PMID:17488656 8'-apo-beta,psi-caroten-8'-al increases expression ISO CXCL9 (Homo sapiens) 6480464 apocarotenal results in increased expression of CXCL9 mRNA CTD PMID:17034753 aflatoxin B1 increases expression ISO Cxcl9 (Rattus norvegicus) 6480464 Aflatoxin B1 results in increased expression of CXCL9 mRNA CTD PMID:25378103 aldehydo-D-glucose multiple interactions EXP 6480464 [lard co-treated with Cholesterol and Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of CXCL9 mRNA CTD PMID:37567420 all-trans-retinoic acid multiple interactions ISO CXCL9 (Homo sapiens) 6480464 [Tretinoin co-treated with Ascorbic Acid] results in increased expression of CXCL9 mRNA CTD PMID:16443354 ammonium chloride affects expression ISO Cxcl9 (Rattus norvegicus) 6480464 Ammonium Chloride affects the expression of CXCL9 mRNA CTD PMID:16483693 antirheumatic drug decreases expression ISO CXCL9 (Homo sapiens) 6480464 Antirheumatic Agents results in decreased expression of CXCL9 mRNA CTD PMID:24449571 aristolochic acid A multiple interactions ISO Cxcl9 (Rattus norvegicus) 6480464 [aristolochic acid I co-treated with aristolochic acid II] results in increased expression of CXCL9 mRNA CTD PMID:23912714 arsane affects expression ISO CXCL9 (Homo sapiens) 6480464 Arsenic affects the expression of CXCL9 protein CTD PMID:24675094 arsenic atom affects expression ISO CXCL9 (Homo sapiens) 6480464 Arsenic affects the expression of CXCL9 protein CTD PMID:24675094 arsenous acid decreases expression ISO CXCL9 (Homo sapiens) 6480464 Arsenic Trioxide results in decreased expression of CXCL9 mRNA CTD PMID:18414637 astemizole decreases expression ISO Cxcl9 (Rattus norvegicus) 6480464 Astemizole results in decreased expression of CXCL9 mRNA CTD PMID:20221588 barium sulfate increases expression ISO Cxcl9 (Rattus norvegicus) 6480464 Barium Sulfate results in increased expression of CXCL9 mRNA CTD PMID:29463257 benzo[a]pyrene multiple interactions EXP 6480464 AHR protein affects the reaction [Benzo(a)pyrene affects the expression of CXCL9 mRNA] CTD PMID:22228805 benzo[a]pyrene increases methylation ISO CXCL9 (Homo sapiens) 6480464 Benzo(a)pyrene results in increased methylation of CXCL9 3' UTR CTD PMID:27901495 benzo[a]pyrene decreases expression EXP 6480464 Benzo(a)pyrene results in decreased expression of CXCL9 mRNA CTD PMID:32417428 benzo[a]pyrene increases expression EXP 6480464 Benzo(a)pyrene results in increased expression of CXCL9 mRNA CTD PMID:23735875 Benzo[k]fluoranthene increases expression EXP 6480464 benzo(k)fluoranthene results in increased expression of CXCL9 mRNA CTD PMID:26377693 beta-carotene increases expression ISO CXCL9 (Homo sapiens) 6480464 beta Carotene results in increased expression of CXCL9 mRNA CTD PMID:17034753 bisphenol A affects expression ISO Cxcl9 (Rattus norvegicus) 6480464 bisphenol A affects the expression of CXCL9 mRNA CTD PMID:25181051 and PMID:30903817 bisphenol A increases expression ISO Cxcl9 (Rattus norvegicus) 6480464 bisphenol A results in increased expression of CXCL9 mRNA CTD PMID:32145629 bleomycin A2 increases expression EXP 6480464 Bleomycin results in increased expression of CXCL9 protein CTD PMID:29175452 buta-1,3-diene decreases expression EXP 6480464 1 and 3-butadiene results in decreased expression of CXCL9 mRNA CTD PMID:29038090 cadmium dichloride increases methylation ISO Cxcl9 (Rattus norvegicus) 6480464 Cadmium Chloride results in increased methylation of CXCL9 promoter CTD PMID:22457795 cadmium dichloride affects expression ISO Cxcl9 (Rattus norvegicus) 6480464 Cadmium Chloride affects the expression of CXCL9 mRNA CTD PMID:25993096 calcium atom multiple interactions ISO CXCL9 (Homo sapiens) 6480464 [[CXCL9 protein binds to and results in increased activity of CXCR3 protein] which results in increased abundance of Calcium] which results in increased expression of EGR1 mRNA more ... CTD PMID:12517959 and PMID:25833952 calcium atom increases abundance ISO CXCL9 (Homo sapiens) 6480464 CXCL9 protein results in increased abundance of Calcium CTD PMID:12517959 calcium(0) multiple interactions ISO CXCL9 (Homo sapiens) 6480464 [[CXCL9 protein binds to and results in increased activity of CXCR3 protein] which results in increased abundance of Calcium] which results in increased expression of EGR1 mRNA more ... CTD PMID:12517959 and PMID:25833952 calcium(0) increases abundance ISO CXCL9 (Homo sapiens) 6480464 CXCL9 protein results in increased abundance of Calcium CTD PMID:12517959 cannabidiol multiple interactions EXP 6480464 Cannabidiol inhibits the reaction [MOG protein modified form results in increased expression of CXCL9 mRNA] CTD PMID:27256343 cannabidiol multiple interactions ISO CXCL9 (Homo sapiens) 6480464 Cannabidiol inhibits the reaction [TNF protein results in increased expression of CXCL9 mRNA] CTD PMID:31250491 carbon nanotube decreases expression EXP 6480464 Nanotubes more ... CTD PMID:25620056 carbon nanotube multiple interactions EXP 6480464 [Vancomycin co-treated with Neomycin co-treated with Cilastatin more ... CTD PMID:32068018 carbon nanotube increases secretion ISO CXCL9 (Homo sapiens) 6480464 Nanotubes and Carbon results in increased secretion of CXCL9 protein CTD PMID:29348435 carbon nanotube increases expression ISO CXCL9 (Homo sapiens) 6480464 Nanotubes and Carbon results in increased expression of CXCL9 mRNA CTD PMID:29348435 carbon nanotube increases expression EXP 6480464 Nanotubes more ... CTD PMID:25554681 more ... ceric oxide affects expression ISO Cxcl9 (Rattus norvegicus) 6480464 ceric oxide affects the expression of CXCL9 mRNA CTD PMID:29463257 chloroquine multiple interactions EXP 6480464 Chloroquine inhibits the reaction [lipopolysaccharide and Escherichia coli O111 B4 results in increased secretion of CXCL9 protein] CTD PMID:22341560 cholesterol multiple interactions EXP 6480464 [Cholesterol co-treated with 1 and 2-dioleoyloxy-3-(trimethylammonium)propane] results in increased expression of CXCL9 mRNA CTD PMID:22129739 choline multiple interactions EXP 6480464 [Dietary Fats co-treated with Choline deficiency] results in increased expression of CXCL9 mRNA and PANX1 gene mutant form inhibits the reaction [[Dietary Fats co-treated with Choline deficiency] results in increased expression of CXCL9 mRNA] CTD PMID:29246445 chondroitin sulfate multiple interactions ISO CXCL9 (Homo sapiens) 6480464 Chondroitin Sulfates inhibits the reaction [CTSB protein results in increased degradation of CXCL9 protein] CTD PMID:25833952 cobalt atom multiple interactions EXP 6480464 [Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of CXCL9 mRNA and TNF protein promotes the reaction [[Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of CXCL9 mRNA] CTD PMID:23503329 cobalt dichloride decreases expression ISO Cxcl9 (Rattus norvegicus) 6480464 cobaltous chloride results in decreased expression of CXCL9 mRNA CTD PMID:24386269 cocaine decreases expression ISO Cxcl9 (Rattus norvegicus) 6480464 Cocaine results in decreased expression of CXCL9 mRNA CTD PMID:17898221 crocidolite asbestos increases expression EXP 6480464 Asbestos and Crocidolite results in increased expression of CXCL9 mRNA CTD PMID:29507420 cyclophosphamide affects expression EXP 6480464 Cyclophosphamide affects the expression of CXCL9 mRNA CTD PMID:18957084 cyclophosphamide decreases expression EXP 6480464 Cyclophosphamide results in decreased expression of CXCL9 protein CTD PMID:21880982 cyclophosphamide increases expression EXP 6480464 Cyclophosphamide results in increased expression of CXCL9 mRNA and Cyclophosphamide results in increased expression of CXCL9 protein CTD PMID:15331540 more ... cyclosporin A decreases expression ISO CXCL9 (Homo sapiens) 6480464 Cyclosporine results in decreased expression of CXCL9 mRNA CTD PMID:27989131 D-glucose multiple interactions EXP 6480464 [lard co-treated with Cholesterol and Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of CXCL9 mRNA CTD PMID:37567420 decabromodiphenyl ether decreases expression ISO Cxcl9 (Rattus norvegicus) 6480464 decabromobiphenyl ether results in decreased expression of CXCL9 mRNA CTD PMID:23914054 deoxynivalenol increases expression EXP 6480464 deoxynivalenol results in increased expression of CXCL9 mRNA CTD PMID:22968694 dexamethasone increases expression EXP 6480464 Dexamethasone results in increased expression of CXCL9 mRNA CTD PMID:21041162 dexamethasone decreases expression EXP 6480464 Dexamethasone results in decreased expression of CXCL9 protein CTD PMID:21880982 dexamethasone multiple interactions EXP 6480464 [Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of CXCL9 mRNA more ... CTD PMID:23503329 and PMID:27568862 dexamethasone multiple interactions ISO CXCL9 (Homo sapiens) 6480464 Dexamethasone inhibits the reaction [Lipopolysaccharides results in increased expression of CXCL9 protein] CTD PMID:27568862 dextran sulfate increases expression EXP 6480464 Dextran Sulfate results in increased expression of CXCL9 mRNA CTD PMID:23894361 diarsenic trioxide decreases expression ISO CXCL9 (Homo sapiens) 6480464 Arsenic Trioxide results in decreased expression of CXCL9 mRNA CTD PMID:18414637 diethyl maleate decreases expression ISO Cxcl9 (Rattus norvegicus) 6480464 diethyl maleate results in decreased expression of CXCL9 mRNA CTD PMID:21161181 diethylstilbestrol increases expression EXP 6480464 Diethylstilbestrol results in increased expression of CXCL9 mRNA CTD PMID:21041162 digoxin multiple interactions EXP 6480464 Digoxin inhibits the reaction [Ethinyl Estradiol results in increased expression of CXCL9 mRNA] and Digoxin inhibits the reaction [Ethinyl Estradiol results in increased expression of CXCL9 protein] CTD PMID:36329302 dimethyl fumarate multiple interactions ISO CXCL9 (Homo sapiens) 6480464 Dimethyl Fumarate inhibits the reaction [IFNG protein results in increased expression of CXCL9 mRNA] CTD PMID:30021835 dimethylarsinic acid multiple interactions EXP 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CXCL9 mRNA CTD PMID:34876320 dioxygen multiple interactions ISO Cxcl9 (Rattus norvegicus) 6480464 [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of CXCL9 mRNA CTD PMID:33729688 diquat decreases expression EXP 6480464 Diquat results in decreased expression of CXCL9 mRNA CTD PMID:36851058 diuron decreases expression ISO Cxcl9 (Rattus norvegicus) 6480464 Diuron results in decreased expression of CXCL9 mRNA CTD PMID:25152437 divanadium pentaoxide increases expression ISO CXCL9 (Homo sapiens) 6480464 vanadium pentoxide results in increased expression of CXCL9 mRNA CTD PMID:17459161 dopamine increases expression ISO Cxcl9 (Rattus norvegicus) 6480464 Dopamine results in increased expression of CXCL9 mRNA CTD PMID:25818600 doxorubicin multiple interactions EXP 6480464 [Vancomycin co-treated with Neomycin co-treated with Cilastatin more ... CTD PMID:32068018 doxorubicin increases expression EXP 6480464 Doxorubicin results in increased expression of CXCL9 mRNA CTD PMID:32068018 doxorubicin decreases expression EXP 6480464 Doxorubicin results in decreased expression of CXCL9 mRNA CTD PMID:28608983 doxorubicin decreases expression ISO CXCL9 (Homo sapiens) 6480464 Doxorubicin results in decreased expression of CXCL9 mRNA CTD PMID:29803840 elemental selenium decreases expression ISO CXCL9 (Homo sapiens) 6480464 Selenium results in decreased expression of CXCL9 mRNA CTD PMID:18997278 epoxiconazole increases expression EXP 6480464 epoxiconazole results in increased expression of CXCL9 mRNA CTD PMID:35436446 ethanol multiple interactions EXP 6480464 [Carbon Tetrachloride co-treated with Ethanol] results in decreased expression of CXCL9 mRNA CTD PMID:30517762 ethanol decreases expression ISO CXCL9 (Homo sapiens) 6480464 Ethanol results in decreased expression of CXCL9 protein CTD PMID:26733986 ethyl methanesulfonate increases expression ISO CXCL9 (Homo sapiens) 6480464 Ethyl Methanesulfonate results in increased expression of CXCL9 mRNA CTD PMID:23649840 flutamide increases expression ISO Cxcl9 (Rattus norvegicus) 6480464 Flutamide results in increased expression of CXCL9 mRNA CTD PMID:24793618 formaldehyde increases expression ISO CXCL9 (Homo sapiens) 6480464 Formaldehyde results in increased expression of CXCL9 mRNA CTD PMID:23649840 fragrance increases expression ISO CXCL9 (Homo sapiens) 6480464 Perfume results in increased expression of CXCL9 mRNA CTD PMID:24768652 fructose multiple interactions EXP 6480464 [lard co-treated with Cholesterol and Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of CXCL9 mRNA CTD PMID:37567420 gadodiamide hydrate increases expression ISO CXCL9 (Homo sapiens) 6480464 gadodiamide results in increased expression of CXCL9 mRNA CTD PMID:20959327 Genipin multiple interactions EXP 6480464 genipin inhibits the reaction [Lipopolysaccharides results in increased expression of CXCL9 mRNA] CTD PMID:22687549 glafenine decreases expression ISO Cxcl9 (Rattus norvegicus) 6480464 Glafenine results in decreased expression of CXCL9 mRNA CTD PMID:24136188 glucose multiple interactions EXP 6480464 [lard co-treated with Cholesterol and Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of CXCL9 mRNA CTD PMID:37567420 glyphosate multiple interactions EXP 6480464 [lard co-treated with Cholesterol and Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of CXCL9 mRNA CTD PMID:37567420 Imipenem-cilastatin multiple interactions EXP 6480464 [Vancomycin co-treated with Neomycin co-treated with Cilastatin more ... CTD PMID:32068018 indole-3-methanol affects expression ISO Cxcl9 (Rattus norvegicus) 6480464 indole-3-carbinol affects the expression of CXCL9 mRNA CTD PMID:21396975 isoprenaline decreases expression EXP 6480464 Isoproterenol results in decreased expression of CXCL9 mRNA CTD PMID:20003209 L-ascorbic acid multiple interactions ISO CXCL9 (Homo sapiens) 6480464 [Tretinoin co-treated with Ascorbic Acid] results in increased expression of CXCL9 mRNA CTD PMID:16443354 lipopolysaccharide increases expression ISO CXCL9 (Homo sapiens) 6480464 Lipopolysaccharides results in increased expression of CXCL9 mRNA and Lipopolysaccharides results in increased expression of CXCL9 protein CTD PMID:27568862 and PMID:35811015 lipopolysaccharide increases expression EXP 6480464 Lipopolysaccharides results in increased expression of CXCL9 mRNA and Lipopolysaccharides results in increased expression of CXCL9 protein CTD PMID:19136613 more ... lipopolysaccharide increases secretion EXP 6480464 Lipopolysaccharides results in increased secretion of CXCL9 protein CTD PMID:16321413 lipopolysaccharide decreases expression EXP 6480464 Lipopolysaccharides results in decreased expression of CXCL9 mRNA CTD PMID:15919760 lipopolysaccharide multiple interactions EXP 6480464 (+)-JQ1 compound inhibits the reaction [Lipopolysaccharides results in increased expression of CXCL9 mRNA] more ... CTD PMID:15154616 more ... lipopolysaccharide increases secretion ISO CXCL9 (Homo sapiens) 6480464 Lipopolysaccharides results in increased secretion of CXCL9 protein CTD PMID:22127699 lipopolysaccharide multiple interactions ISO CXCL9 (Homo sapiens) 6480464 coagulin-L inhibits the reaction [Lipopolysaccharides results in increased expression of CXCL9 protein] more ... CTD PMID:27568862 and PMID:35811015 luteolin multiple interactions EXP 6480464 Luteolin inhibits the reaction [Lipopolysaccharides results in increased expression of CXCL9 mRNA] and Luteolin inhibits the reaction [Poly I-C results in increased expression of CXCL9 mRNA] CTD PMID:19426678 metam multiple interactions EXP 6480464 methyldithiocarbamate inhibits the reaction [Lipopolysaccharides results in increased secretion of CXCL9 protein] and methyldithiocarbamate inhibits the reaction [Poly I-C results in increased secretion of CXCL9 protein] CTD PMID:16321413 and PMID:24056979 metformin decreases expression ISO Cxcl9 (Rattus norvegicus) 6480464 Metformin results in decreased expression of CXCL9 mRNA CTD PMID:31324951 methapyrilene increases expression ISO Cxcl9 (Rattus norvegicus) 6480464 Methapyrilene results in increased expression of CXCL9 mRNA CTD PMID:30467583 methylarsonic acid multiple interactions EXP 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CXCL9 mRNA CTD PMID:34876320 monosodium L-glutamate multiple interactions EXP 6480464 [Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of CXCL9 mRNA CTD PMID:19001666 mycotoxin increases expression EXP 6480464 Mycotoxins results in increased expression of CXCL9 mRNA CTD PMID:19818335 N-nitrosodimethylamine increases expression ISO Cxcl9 (Rattus norvegicus) 6480464 Dimethylnitrosamine results in increased expression of CXCL9 mRNA CTD PMID:25380136 N-nitrosodimethylamine affects expression EXP 6480464 Dimethylnitrosamine affects the expression of CXCL9 mRNA CTD PMID:11356909 neomycin multiple interactions EXP 6480464 [Vancomycin co-treated with Neomycin co-treated with Cilastatin more ... CTD PMID:32068018 nickel atom multiple interactions EXP 6480464 [Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of CXCL9 mRNA and TNF protein promotes the reaction [[Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of CXCL9 mRNA] CTD PMID:23503329 nickel atom increases expression ISO CXCL9 (Homo sapiens) 6480464 Nickel results in increased expression of CXCL9 mRNA CTD PMID:24768652 and PMID:25583101 nickel dichloride affects expression ISO Cxcl9 (Rattus norvegicus) 6480464 nickel chloride affects the expression of CXCL9 mRNA CTD PMID:22110744 nickel dichloride multiple interactions ISO CXCL9 (Homo sapiens) 6480464 nickel chloride inhibits the reaction [lipopolysaccharide and E. coli O26-B6 results in increased expression of CXCL9 mRNA] CTD PMID:23090859 nimesulide multiple interactions EXP 6480464 [nimesulide results in decreased activity of PTGS2 protein] which results in increased expression of CXCL9 mRNA CTD PMID:22561872 oxaliplatin multiple interactions ISO Cxcl9 (Rattus norvegicus) 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of CXCL9 mRNA CTD PMID:25729387 ozone multiple interactions EXP 6480464 [LEP gene mutant form results in increased susceptibility to Ozone] which results in increased expression of CXCL9 protein CTD PMID:27472835 paracetamol affects expression EXP 6480464 Acetaminophen affects the expression of CXCL9 mRNA CTD PMID:17562736 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of CXCL9 mRNA CTD PMID:29246445 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of CXCL9 mRNA CTD PMID:12153990 and PMID:15578514 paracetamol multiple interactions EXP 6480464 IFNG protein promotes the reaction [Acetaminophen results in increased expression of CXCL9 mRNA] more ... CTD PMID:12153990 more ... perfluorooctane-1-sulfonic acid multiple interactions EXP 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of CXCL9 mRNA CTD PMID:36331819 pevonedistat affects expression ISO CXCL9 (Homo sapiens) 6480464 pevonedistat affects the expression of CXCL9 mRNA CTD PMID:24634471 phenobarbital increases expression EXP 6480464 Phenobarbital results in increased expression of CXCL9 mRNA CTD PMID:23091169 phorbol 13-acetate 12-myristate multiple interactions EXP 6480464 IL17RA gene mutant form inhibits the reaction [Tetradecanoylphorbol Acetate results in decreased expression of CXCL9 mRNA] CTD PMID:22359662 phorbol 13-acetate 12-myristate decreases expression EXP 6480464 Tetradecanoylphorbol Acetate results in decreased expression of CXCL9 mRNA CTD PMID:22359662 pirinixic acid multiple interactions EXP 6480464 [pirinixic acid co-treated with PPARA] results in decreased expression of CXCL9 mRNA CTD PMID:20813756 pirinixic acid decreases expression EXP 6480464 pirinixic acid results in decreased expression of CXCL9 mRNA CTD PMID:18445702 and PMID:20813756 poly(I:C) multiple interactions EXP 6480464 Luteolin inhibits the reaction [Poly I-C results in increased expression of CXCL9 mRNA] and methyldithiocarbamate inhibits the reaction [Poly I-C results in increased secretion of CXCL9 protein] CTD PMID:19426678 and PMID:24056979 poly(I:C) increases secretion EXP 6480464 Poly I-C results in increased secretion of CXCL9 protein CTD PMID:24056979 poly(I:C) increases expression EXP 6480464 Poly I-C results in increased expression of CXCL9 mRNA CTD PMID:19426678 potassium dichromate increases expression EXP 6480464 Potassium Dichromate results in increased expression of CXCL9 mRNA CTD PMID:23608068 progesterone multiple interactions ISO CXCL9 (Homo sapiens) 6480464 [Progesterone co-treated with Estradiol] results in increased expression of CXCL9 mRNA CTD PMID:18692832 progesterone increases expression ISO CXCL9 (Homo sapiens) 6480464 Progesterone results in increased expression of CXCL9 mRNA CTD PMID:18692832 protein kinase inhibitor multiple interactions ISO CXCL9 (Homo sapiens) 6480464 Protein Kinase Inhibitors inhibits the reaction [Biological Products results in increased expression of CXCL9 mRNA] and Protein Kinase Inhibitors inhibits the reaction [Biological Products results in increased expression of CXCL9 protein] CTD PMID:24471457 reactive oxygen species multiple interactions ISO CXCL9 (Homo sapiens) 6480464 [CXCL9 protein results in increased activity of Reactive Oxygen Species] which results in decreased transport of Sodium CTD PMID:12517959 reactive oxygen species increases activity ISO CXCL9 (Homo sapiens) 6480464 CXCL9 protein results in increased activity of Reactive Oxygen Species CTD PMID:12517959 resveratrol decreases expression EXP 6480464 resveratrol results in decreased expression of CXCL9 mRNA CTD PMID:21189227 rotenone decreases expression ISO Cxcl9 (Rattus norvegicus) 6480464 Rotenone results in decreased expression of CXCL9 mRNA CTD PMID:28374803 roxarsone decreases expression ISO CXCL9 (Homo sapiens) 6480464 Roxarsone results in decreased expression of CXCL9 mRNA CTD PMID:18414637 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO CXCL9 (Homo sapiens) 6480464 S-(1 and 2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in increased expression of CXCL9 mRNA] CTD PMID:35811015 selenium atom decreases expression ISO CXCL9 (Homo sapiens) 6480464 Selenium results in decreased expression of CXCL9 mRNA CTD PMID:18997278 silicon dioxide increases expression ISO CXCL9 (Homo sapiens) 6480464 Silicon Dioxide results in increased expression of CXCL9 mRNA CTD PMID:21540303 silicon dioxide increases expression ISO Cxcl9 (Rattus norvegicus) 6480464 Silicon Dioxide results in increased expression of CXCL9 mRNA CTD PMID:22431001 and PMID:32721576 silicon dioxide increases expression EXP 6480464 Silicon Dioxide results in increased expression of CXCL9 mRNA CTD PMID:23221170 and PMID:29341224 sodium arsenate multiple interactions EXP 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CXCL9 mRNA CTD PMID:34876320 sodium arsenite multiple interactions ISO CXCL9 (Homo sapiens) 6480464 Pertussis Toxin inhibits the reaction [sodium arsenite results in decreased expression of CXCL9 mRNA] CTD PMID:19349368 sodium arsenite multiple interactions EXP 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CXCL9 mRNA CTD PMID:34876320 sodium arsenite decreases expression EXP 6480464 sodium arsenite results in decreased expression of CXCL9 mRNA CTD PMID:37682722 sodium arsenite decreases expression ISO CXCL9 (Homo sapiens) 6480464 sodium arsenite results in decreased expression of CXCL9 mRNA CTD PMID:19349368 sodium arsenite increases expression EXP 6480464 sodium arsenite results in increased expression of CXCL9 mRNA CTD PMID:21911445 sodium atom multiple interactions ISO CXCL9 (Homo sapiens) 6480464 [CXCL9 protein results in increased activity of Reactive Oxygen Species] which results in decreased transport of Sodium CTD PMID:12517959 sterigmatocystin increases expression EXP 6480464 Sterigmatocystin results in increased expression of CXCL9 mRNA CTD PMID:19818335 sulindac multiple interactions EXP 6480464 Sulindac inhibits the reaction [IFNG protein results in increased expression of CXCL9 mRNA] CTD PMID:17010317 tamibarotene decreases expression EXP 6480464 tamibarotene results in decreased expression of CXCL9 mRNA CTD PMID:20861477 testosterone increases expression EXP 6480464 Testosterone results in increased expression of CXCL9 mRNA CTD PMID:15788153 testosterone multiple interactions ISO Cxcl9 (Rattus norvegicus) 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CXCL9 mRNA CTD PMID:32741896 tetrachloromethane multiple interactions EXP 6480464 [Carbon Tetrachloride co-treated with Ethanol] results in decreased expression of CXCL9 mRNA CTD PMID:30517762 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of CXCL9 mRNA CTD PMID:31919559 thioacetamide increases expression ISO Cxcl9 (Rattus norvegicus) 6480464 Thioacetamide results in increased expression of CXCL9 mRNA CTD PMID:34492290 titanium dioxide increases expression EXP 6480464 titanium dioxide results in increased expression of CXCL9 mRNA and titanium dioxide results in increased expression of CXCL9 protein CTD PMID:21259345 more ... TMC-120A decreases expression EXP 6480464 TMC 120A results in decreased expression of CXCL9 mRNA CTD PMID:19818335 tofacitinib multiple interactions EXP 6480464 tofacitinib inhibits the reaction [IFNG protein results in increased expression of CXCL9 mRNA] CTD PMID:24213371 tofacitinib decreases expression ISO CXCL9 (Homo sapiens) 6480464 tofacitinib results in decreased expression of CXCL9 mRNA CTD PMID:22941906 toluene 2,4-diisocyanate decreases expression EXP 6480464 Toluene 2 and 4-Diisocyanate results in decreased expression of CXCL9 mRNA CTD PMID:11379042 toluene 2,4-diisocyanate increases expression EXP 6480464 Toluene 2 and 4-Diisocyanate results in increased expression of CXCL9 mRNA CTD PMID:19647056 more ... topotecan multiple interactions ISO Cxcl9 (Rattus norvegicus) 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of CXCL9 mRNA CTD PMID:25729387 tremolite asbestos increases expression EXP 6480464 tremolite results in increased expression of CXCL9 mRNA CTD PMID:29279043 trimellitic anhydride increases expression ISO Cxcl9 (Rattus norvegicus) 6480464 trimellitic anhydride results in increased expression of CXCL9 mRNA CTD PMID:21893156 valproic acid decreases expression ISO CXCL9 (Homo sapiens) 6480464 Valproic Acid results in decreased expression of CXCL9 mRNA CTD PMID:29154799 valproic acid decreases expression ISO Cxcl9 (Rattus norvegicus) 6480464 Valproic Acid results in decreased expression of CXCL9 mRNA CTD PMID:35594946 vancomycin multiple interactions EXP 6480464 [Vancomycin co-treated with Neomycin co-treated with Cilastatin more ... CTD PMID:32068018 vincristine increases expression ISO CXCL9 (Homo sapiens) 6480464 Vincristine results in increased expression of CXCL9 mRNA CTD PMID:23649840 zaragozic acid A increases expression EXP 6480464 squalestatin 1 results in increased expression of CXCL9 mRNA CTD PMID:27225895 zaragozic acid A increases expression ISO Cxcl9 (Rattus norvegicus) 6480464 squalestatin 1 results in increased expression of CXCL9 mRNA CTD PMID:27225895 zearalenone increases expression ISO CXCL9 (Homo sapiens) 6480464 Zearalenone results in increased expression of CXCL9 mRNA CTD PMID:27757495 zinc atom multiple interactions EXP 6480464 [Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of CXCL9 mRNA and TNF protein promotes the reaction [[Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of CXCL9 mRNA] CTD PMID:23503329 zinc oxide increases expression EXP 6480464 Zinc Oxide results in increased expression of CXCL9 CTD PMID:19897006 zinc(0) multiple interactions EXP 6480464 [Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of CXCL9 mRNA and TNF protein promotes the reaction [[Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of CXCL9 mRNA] CTD PMID:23503329